Jim Gottesman

Suggest Changes
Learn More
PURPOSE Bacillus Calmette-Guerin (BCG) immunotherapy has been widely accepted as the optimal treatment for carcinoma in situ and high grade superficial transitional cell carcinoma. However,(More)